Pooja Hingorani

Efficacy and Safety of Dabrafenib in Pediatric Patients with <i>BRAF</i> V600 Mutation–Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study

Darren Hargrave, Éric Bouffet, Uri Tabori et al. · Clinical Cancer Research · 2019 · 212 citations

Medicine, Oncology, Pediatrics +17

Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma

Danielle M. Lussier, John L. Johnson, Pooja Hingorani et al. · Journal for ImmunoTherapy of Cancer · 2015 · 199 citations · Full text

Life Sciences, Immunology, Oncology +17

Enhanced T-Cell Immunity to Osteosarcoma Through Antibody Blockade of PD-1/PD-L1 Interactions

Danielle M. Lussier, Lauren O’Neill, Lizbeth M. Nieves et al. · Journal of Immunotherapy · 2015 · 192 citations · Full text

Medicine, Immunology, Oncology +17

Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children’s Oncology Group

Leo Mascarenhas, Yueh-Yun Chi, Pooja Hingorani et al. · Journal of Clinical Oncology · 2019 · 112 citations · Full text

Medicine, Oncology, Pharmacology +13

Incidence and Outcomes of Desmoplastic Small Round Cell Tumor: Results from the Surveillance, Epidemiology, and End Results Database

Christina K. Lettieri, Pamela Garcia‐Filion, Pooja Hingorani · Journal of Cancer Epidemiology · 2014 · 107 citations · Full text

Veterinary Medicine, Oncology, Surgery +16